Cell line name NCC-GCTB1-C1
Accession CVCL_A9QC
Resource Identification Initiative To cite this cell line use: NCC-GCTB1-C1 (RRID:CVCL_A9QC)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 13 hours (PubMed=32815117).
Derived from site: In situ; Bone, right distal radius; UBERON=UBERON_0004407.
Sequence variations
Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=32815117).
Disease Malignancy in giant cell tumor of bone (NCIt: C4304)
Giant cell tumor of bone (ORDO: Orphanet_363976)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 53Y
Category Cancer cell line
STR profile

Source(s): PubMed=32815117


Amelogenin X,Y
D5S818 11,12
D7S820 11,12
D13S317 11,12
D16S539 9
D21S11 29,32.2
TH01 8,9
TPOX 9,11
vWA 14,16

PubMed=32815117; DOI=10.1007/s13577-020-00415-w
Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone.
Hum. Cell 33:1321-1328(2020)

Encyclopedic resources Wikidata; Q102114580

Additional information

Weight N/A
User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-GCTB1-C1”

Your email address will not be published. Required fields are marked *